IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study

INTRODUCTION: IDegLira was shown to maintain glycemic control while reducing risk of hypoglycemia and body weight gain. The REX study was designed to generate real-world evidence on the use of IDegLira in Italian clinical practice in two different subgroups of patients, those switching to IDegLira f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadini, Gian Paolo, Buzzetti, Raffaella, Fittipaldi, Maria Rosa, D’Incau, Ferruccio, Da Porto, Andrea, Girelli, Angela, Simoni, Lucia, Lastoria, Giusi, Consoli, Agostino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309107/
https://www.ncbi.nlm.nih.gov/pubmed/35717487
http://dx.doi.org/10.1007/s13300-022-01287-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309107/
https://www.ncbi.nlm.nih.gov/pubmed/35717487
http://dx.doi.org/10.1007/s13300-022-01287-z

Ejemplares similares